Compare funds
Pick up to 10 funds. Compare funds from the same category for a fair reading.
Growth of ₹10,000
Basics
| Kotak ESG Exclusionary Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Category | Sectoral / Thematic | Sectoral / Thematic |
| Plan | Regular | Regular |
| Fund house | Kotak | HDFC |
| NAV | ₹17.6410 | ₹22.8170 |
| NAV date | 20 Nov 2026 | 20 Nov 2026 |
| History | 5.9 years | 3.1 years |
| Expense ratio | 2.5% | 2.1% |
| Stars | ★★★★★ | ★★★★★ |
| Growth Score | 36.50 | 93.90 |
Returns
| Kotak ESG Exclusionary Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 1 month | +10.65% | +12.87% |
| 3 months | +3.15% | +6.85% |
| 6 months | +9.50% | +17.20% |
| YTD | −0.41% | +32.43% |
| 1 year | −1.03% | +30.73% |
| 3 years (CAGR) | +9.54% | +29.16% |
| 5 years (CAGR) | +7.34% | — |
| 10 years (CAGR) | — | — |
| Since launch | +10.03% | +30.28% |
Risk
| Kotak ESG Exclusionary Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Volatility | 14.9% | 15.8% |
| Downside volatility | 10.7% | 8.6% |
| Sharpe | 0.20 | 1.44 |
| Sortino | 0.29 | 2.64 |
| Calmar | 0.52 | 1.94 |
| Return / risk | 0.64 | 1.85 |
| Deepest fall | −22.42% | −15.07% |
| Days to recover | 392 | 133 |
| Below its high | −3.32% | +0.00% |
Against benchmark
| Kotak ESG Exclusionary Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Alpha | — | +6.36% |
| Beta | — | 0.97 |
| R² | — | 85.0% |
| Up capture | — | 106.7% |
| Down capture | — | 74.4% |
| Tracking error | — | 6.1% |
| Information ratio | — | 0.97 |
| Treynor | — | 0.22 |
Consistency
| Kotak ESG Exclusionary Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| Best 1-year | +37.01% | +64.96% |
| Middle 1-year | +6.31% | +21.84% |
| Worst 1-year | −11.54% | +0.52% |
| 1-year periods with a loss | 32.2% | 0.0% |
| Middle 3-year | +12.59% | +28.68% |
| Positive months | 63.9% | 69.4% |
| Best day | +4.01% | +3.19% |
| Worst day | −5.91% | −3.62% |
| Worst 5% day | −1.38% | −1.50% |
| Positive days | 53.1% | 58.1% |
| NAVs a year | 247 | 247 |
SIP of ₹10,000 a month
| Kotak ESG Exclusionary Strategy Fund | HDFC Pharma and Healthcare Fund | |
|---|---|---|
| 5-year XIRR | +8.46% | — |
| 5-year value | ₹7,45,834 | — |
| 3-year XIRR | +5.29% | +26.26% |
| 1-year XIRR | +8.49% | +39.84% |
Holdings overlap i
Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.